Psoriasis drug showdown: which works better?
NCT ID NCT07337434
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two drugs, methotrexate and apremilast, to see which works better for moderate to severe plaque psoriasis. About 106 adults with psoriasis will take one of the drugs for 12 weeks. The goal is to find which treatment reduces skin symptoms more effectively.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PLAQUE PSORIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MTI-HMC Peshawar
RECRUITINGPeshawar, Khyber Pukhtunkhwa, 25000, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single cream tackle both skin and nail psoriasis?
- Psoriasis Drug's skin gene secrets revealed in small trial
- Psoriasis drug showdown: which pill works better?
- New hope for nail psoriasis: tildrakizumab shows promise in trial
- New drug bimekizumab shows promise for psoriasis in early trial
- New psoriasis drug shows promise in chinese trial